BIOSPECIFICS TECHNOLOGIES CORP·4

May 23, 5:34 PM ET

Chao Jennifer M 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 23, 2019

Insider Transaction Report

Form 4
Period: 2019-05-22
Transactions
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2019-05-22$37.64/sh+8,000$301,1209,313 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-05-228,0001,687 total
    Exercise: $37.64Exp: 2025-04-22Common Stock (8,000 underlying)
Footnotes (1)
  • [F1]The option vested in four equal annual installments beginning on the first anniversary of the date of grant (4/22/2015).

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES